用阿达利穆马布治疗的皮炎:一个病例报告
Adel Alsantali1, Razan Baghdadi2, Yara Alghamdi3,4
1Department of Dermatology King Fahd Armed Forces Hospital Jeddah Saudi Arabia.
Clinical case reports
|December 11, 2023
概括
脱毛发炎 (FD) 是一种罕见的头皮疾病,导致炎症和脱发. 对于中度至严重的病例,生物药物可能是治疗炎症的有益选择.
科学领域:
- 皮肤病学 皮肤病学
- 皮肤病理学 皮肤病理学
- 三学是指三学的学科.
背景情况:
- 卡尔万斯毛囊炎 (FD) 是一种罕见的中性友性痕性脱发症.
- 它表现为头皮炎症,,疹和特有的头发.
- 目前的治疗主要涉及局部或口服抗生素.
研究的目的:
- 探索用于毛囊炎的替代治疗策略.
- 突出生物制剂在管理中度至重度FD方面的潜力.
- 强调解决正在进行的炎症过程的重要性.
主要方法:
- 审查现有的关于毛囊炎治疗的文献.
- 对涉及FD的炎症机制的分析.
- 考虑基于其免疫调节性质的生物疗法.
主要成果:
- 抗生素是FD的标准初始治疗方法.
- 生物药物为耐火性或严重病例提供了潜在的治疗途径.
- 生物药物可能有助于稳定炎症过程,并防止进一步的痕.
结论:
- 应考虑对中度至重度的毛囊炎的生物治疗.
- 通过适当的治疗,早期干预可以帮助保存毛囊.
- 需要进一步的研究来确定生物药物在FD中的有效性和安全性.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
142
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
142
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168
Inflammatory Bowel Disease IV: Pharmacological Management
129
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
129
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
121
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
121
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
335
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
335


